Clinical and economic comparison of utilization of reslizumab, mepolizumab and benralizumab in the treatment of severe eosinophilic asthma - PDF (Russian)
Copyright (c) 2020 Zyryanov S.K., Avdeev S.N., Ivanov D.A., Zhuravleva M.V., Kniajeskaia N.P., Matveev N.V., Nenasheva N.A., Fomina D.S., Frolov M.I.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.